Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 24;8(7):ofab343.
doi: 10.1093/ofid/ofab343. eCollection 2021 Jul.

Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP

Affiliations
Case Reports

Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP

Muzamil Jawed et al. Open Forum Infect Dis. .

Abstract

Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP.

Keywords: COVID-19; Pfizer; SARS-CoV-2; immune thrombocytopenic purpura; vaccination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Peripheral smear with thrombocytopenia and normal red blood cell (RBC) morphology.
Figure 2.
Figure 2.
Peripheral smear with thrombocytopenia normal red blood cell (RBC) morphology.

References

    1. COVID-19 vaccine tracker. New York State. Available at:https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker. Accessed 02/20/21.
    1. The Vaccine Adverse Event Reporting System (VAERS) request. Centers for Disease Control and Prevention (CDC). Available at: https://wonder.cdc.gov/vaers.html. Accessed 02/20/21.
    1. Justiz Vaillant AA, Gupta N.. ITP-Immune Thrombocytopenic Purpura. Treasure Island, FL: StatPearls Publishing; 2020. - PubMed
    1. Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med. In press. - PMC - PubMed
    1. Rodeghiero F, Stasi R, Gernsheimer T, et al. . Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113:2386–93. - PubMed

Publication types